Skip to main content
STRIDES PHARMA SCIENCE LIMITED logo

STRIDES PHARMA SCIENCE LIMITED — Investor Relations & Filings

Ticker · STAR ISIN · INE939A01011 LEI · 335800WHFYXUCHR9DD10 BSE.NS Manufacturing
Open in API
Filings indexed 1,200 across all filing types
Latest filing 2022-10-19 Regulatory Filings
Country IN India
Listing BSE.NS STAR

About STRIDES PHARMA SCIENCE LIMITED

https://www.strides.com

Strides Pharma Science Limited is a global pharmaceutical organization focused on the development and manufacture of IP-led niche finished dosage formulations. The company’s product portfolio encompasses a wide range of therapeutic areas, specializing in complex oral solids, softgel capsules, topicals, and liquids. It maintains a significant presence in highly regulated markets, including the United States, Europe, and Australia, while also serving institutional and emerging markets. The company operates multiple manufacturing facilities globally, many of which are approved by major international regulatory agencies such as the USFDA. Strides emphasizes research and development to drive innovation in specialized delivery systems and difficult-to-manufacture products, positioning itself as a key player in the global generic pharmaceutical landscape.

Recent filings

Filing Released Lang Actions
Loss of share certificate
Regulatory Filings
2022-10-19 English
Share Warrants
Share Issue/Capital Change Classification · 100% confidence The document is a short announcement dated September 16, 2022, addressed to stock exchanges regarding the allotment of shares following the conversion of warrants to equity shares. It details the increase in paid-up share capital and the number of shares outstanding. There is no financial data, analysis, or detailed report content. The document is an announcement of a capital change event, specifically the allotment of shares and increase in share capital. According to the filing definitions, this fits the category of 'Share Issue/Capital Change' (SHA). The document length is short and it is not a report itself but an announcement of a capital change event.
2022-09-16 English
Loss of share certificate
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding compliance under SEBI regulations about the issuance of duplicate share certificates to a shareholder. It includes details of the shareholder, old and new certificate numbers, and proof of dispatch. The content is procedural and regulatory in nature, related to share certificate management and compliance, not a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial data. The document is short (1850 characters) and serves as a regulatory compliance notification. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-09-15 English
Loss of share certificate
Regulatory Filings Classification · 95% confidence The document is a compliance communication under SEBI regulations regarding the issuance of duplicate share certificates to a shareholder. It includes details of the shareholder, old and new certificate numbers, and proof of dispatch. There is no financial data, report, or presentation content. The document is a regulatory announcement related to share certificate issuance and compliance, not a financial report or meeting material. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2022-09-15 English
General updates
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the re-appointment of the statutory auditors of the company. It references the approval at the 31st Annual General Meeting (AGM) and provides details about the auditors, including their profile and term of appointment. The document is short (3095 characters) and serves as a disclosure under SEBI Listing Regulations about the auditor re-appointment. It does not contain any financial statements, audit opinions, or detailed audit results, so it is not an Audit Report (AR). It is also not an Annual Report (10-K) or any other financial report. The document is an announcement related to board/management information specifically about auditors, which falls under the category of Board/Management Information (MANG). Therefore, the correct classification is MANG with high confidence.
2022-09-10 English
Annual General Meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is dated September 10, 2022, and concerns the outcome of the 31st Annual General Meeting (AGM) of Strides Pharma Science Limited held on September 9, 2022. It includes detailed voting results, a report of the scrutinizer pursuant to the Companies Act, 2013, and SEBI Listing Regulations. The content focuses on the official results of shareholder votes on various resolutions at the AGM, including adoption of financial statements, re-appointment of directors, and appointment of auditors. The document is not the AGM notice or presentation materials but the official disclosure of voting results and scrutinizer's report. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length (15,000 characters) and detailed voting data confirm it is not a brief announcement or a report publication notice. Confidence is high due to explicit references to voting results and regulatory compliance under SEBI Listing Regulations and Companies Act.
2022-09-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.